サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1777258

虚血性脳卒中手術の世界市場：手術タイプ・製品タイプ・エンドユーザー・地域別 (～2035年)

Global Ischemic Stroke Surgery Market Research Report by Type of Surgery, by Product Type, by End-User, and by Region Industry Forecast till 2035

出版日
ページ情報
英文 115 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
虚血性脳卒中手術の世界市場：手術タイプ・製品タイプ・エンドユーザー・地域別 (～2035年)
出版日: 2025年06月15日
発行: Market Research Future
ページ情報: 英文 115 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の虚血性脳卒中手術の市場規模は、2021年の22億9,116万米ドルから、CAGR 8.70％で推移し、2035年末には72億6,615万米ドルに達すると予測されています。

虚血性脳卒中手術とは、血栓を取り除き、脳への血流を回復させるための医療処置であり、急性虚血性脳卒中を患った患者において、脳損傷を最小限に抑え、回復の可能性を高める効果があります。

運動不足や生活習慣の乱れが、世界の虚血性脳卒中手術市場の需要を押し上げています。高度な手術技術や機器の導入により、治療効果が向上しており、患者も回復が早い低侵襲の手術方法を選ぶ傾向が強まっています。

一方で、医療インフラの整備不足や熟練医療従事者の不足が、この分野の進展を妨げている要因となっています。それでも、研究開発や投資の拡大により、虚血性脳卒中手術市場は新たな発展の道を見出しつつあります。

地域別分析

北米市場は、脳卒中症例の多さと血管内血栓除去術のような最先端技術の利用増加により、現在も急速に拡大しています。高齢者人口の増加、認知度の向上、技術の進歩などが市場拡大の原動力となっています。

新しい研究と血栓除去術などの治療の成功が、欧州市場の成長を促進しています。同地域の脳卒中治療成績が向上しているのは、医療の革新への強力な支援によるものです。

アジア太平洋地域の市場は急速に拡大しており、各国政府が研究や医療支出を増やしています。韓国、日本、インドなどの国々では、新しい治療法がより広く利用できるようになり、患者の回復に役立っています。

ラテンアメリカ・中東・アフリカ地域では脳卒中関連疾患が増加しており、手術の需要が高まっています。より良い医療インフラと保健プログラムが、これらの地域の世界市場での成長を支えています。

当レポートでは、世界の虚血性脳卒中手術の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

  • 促進要因
    • 運動不足と座りがちな生活習慣の増加
    • 技術的に高度な製品の採用と発売
    • 低侵襲手術の需要の高まり
  • 抑制要因
    • 医療施設の不足
    • 熟練した専門家の不足
  • 機会
    • 研究開発活動と投資

第5章 市場要因分析

  • バリューチェーン分析
  • ポーターのファイブフォースモデル
  • COVID-19が世界の虚血性脳卒中手術市場に与える影響
  • 疫学分析
  • 規制分析/医療制度

第6章 世界の虚血性脳卒中手術市場：手術タイプ別

  • 概要
  • 血栓除去術
  • 血管再生手術
  • 頸動脈内膜切除術
  • 血管形成術
  • その他

第7章 世界の虚血性脳卒中手術市場：製品タイプ別

  • 概要
  • カテーテル
  • 吸引システム
  • ガイドワイヤー
  • マイクロカテーテル
  • その他

第8章 世界の虚血性脳卒中手術市場：エンドユーザー別

  • 概要
  • 病院・診療所
  • 外来手術センター
  • その他

第9章 世界の虚血性脳卒中手術市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他
  • その他の地域
    • 中東
    • アフリカ
    • ラテンアメリカ

第10章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合ベンチマーキング
  • 世界の虚血性脳卒中手術市場における主要な成長戦略
  • 世界の虚血性脳卒中手術市場における開発件数でトップの企業
  • 主要な開発分析
  • 主な展開・成長戦略
  • 財務マトリックス

第11章 企業プロファイル

  • MEDTRONIC PLC
  • ABBOTT LABORATORIES
  • BOSTON SCIENTIFIC CORPORATION
  • CORDIS CORPORATION
  • KONINKLIJKE PHILIPS N.V
  • STRYKER
  • IMPERATIVE CARE
  • JOHNSON & JOHNSON SERVICES, INC.
  • PENUMBRA, INC.
  • PHENOXYHENOX GMBH

第12章 付録

図表

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 NUMBER OF PROCEDURES FOR THROMBECTOMY, BY REGION (2021)
  • TABLE 4 NUMBER OF PROCEDURES FOR THROMBECTOMY, BY COUNTRY (2021)
  • TABLE 5 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 6 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR THROMBECTOMY, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 7 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR REVASCULARIZATION SURGERY, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 8 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR CAROTID ENDARTERECTOMY, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 9 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR ANGIOPLASTY, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 10 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 11 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 12 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR CATHETER, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 13 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR ASPIRATION SYSTEM, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 14 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR GUIDEWIRE, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 15 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR MICROCATHETER, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 16 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 17 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 18 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 19 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR AMBULATORY SURGERY CENTRES, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 20 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS BY REGION, 2018-2035 (USD MILLION)
  • TABLE 21 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 22 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
  • TABLE 23 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 24 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 25 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 26 US: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 27 US: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 28 US: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 29 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 30 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 31 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 32 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
  • TABLE 33 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 34 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 35 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 36 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 37 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 38 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 39 UK: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 40 UK: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 41 UK: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 42 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 43 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 44 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 45 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 46 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 47 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 48 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 49 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 50 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 51 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 52 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 53 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
  • TABLE 55 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 56 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 57 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 58 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 59 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 60 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 61 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 62 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 63 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 64 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 65 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 66 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 67 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 68 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 69 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 70 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 71 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 72 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 73 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 74 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 75 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 76 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018-2035(USD MILLION)
  • TABLE 77 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 78 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 79 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 80 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 81 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 82 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 83 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 84 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 85 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 86 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 87 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 88 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 89 MAJOR PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • TABLE 90 MOST ACTIVE PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • TABLE 91 PRODUCT LAUNCH/PRODUCT APPROVAL
  • TABLE 92 MERGER & ACQUISITIONS
  • TABLE 93 AGREEMENT/MARKETING STRATEGIES
  • TABLE 94 MEDTRONIC PLC: PRODUCTS OFFERED
  • TABLE 95 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED
  • TABLE 96 ABBOTT LABORATORIES: KEY DEVELOPMENTS
  • TABLE 97 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 98 CORDIS CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 99 KONINKLIJKE PHILIPS N.V .: PRODUCTS/SERVICES OFFERED
  • TABLE 100 STRYKER: PRODUCTS OFFERED
  • TABLE 101 STRYKER: KEY DEVELOPMENTS
  • TABLE 102 IMPERATIVE CARE: PRODUCTS OFFERED
  • TABLE 103 IMPERATIVE CARE: KEY DEVELOPMENTS
  • TABLE 104 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
  • TABLE 105 JOHNSON & JOHNSON SERVICES, INC.: KEY DEVELOPMENTS
  • TABLE 106 PENUMBRA, INC.: PRODUCTS OFFERED
  • TABLE 107 PENUMBRA, INC.: KEY DEVELOPMENTS
  • TABLE 108 PHENOX GMBH: PRODUCTS OFFERED
  • TABLE 109 PHENOX GMBH: KEY DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • FIGURE 5 DRIVERS: IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT: IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ISCHEMIC STROKE MARKET
  • FIGURE 1 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2021 & 2035 (USD MILLION)
  • FIGURE 2 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2021 & 2035 (USD MILLION)
  • FIGURE 3 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2021 & 2035 (USD MILLION)
  • FIGURE 4 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY REGION 2021 & 2035 (USD MILLION)
  • FIGURE 5 GLOBAL: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY REGION,
  • FIGURE 6 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY
  • FIGURE 7 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY 2021 & 2035 (USD MILLION)
  • FIGURE 8 EUROPE: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY
  • FIGURE 9 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY 2021 & 2035 (USD MILLION)
  • FIGURE 10 ASIA PACIFIC: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY,
  • FIGURE 11 ASIA PACIFIC ISCHEMIC STROKE SURGERY MARKET SHARE, BY COUNTRY 2021 & 2035 (USD MILLION)
  • FIGURE 12 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY REGION,
  • FIGURE 13 REST OF THE WORLD ISCHEMIC STROKE SURGERY MARKET SHARE, BY REGION 2021 & 2035 (USD MILLION)
  • FIGURE 14 MAJOR MANUFACTURERS MARKET SHARE (%) ANALYSIS,
  • FIGURE 15 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 16 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • FIGURE 17 GLOBAL ISCHEMIC STROKE SURGERY MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 18 SALES (USD MILLION),
  • FIGURE 19 RESEARCH & DEVELOPMENT EXPENDITURE
  • FIGURE 20 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 21 MEDTRONIC PLC: SWOT ANALYSIS
  • FIGURE 22 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 23 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 24 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 25 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS
  • FIGURE 26 STRYKER: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 27 STRYKER: SWOT ANALYSIS
  • FIGURE 28 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 29 JOHNSON & JOHNSON SERVICES INC.: SWOT ANALYSIS
  • FIGURE 30 PENUMBRA, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 31 PENUMBRA, INC.: SWOT ANALYSIS
目次
Product Code: MRFR/HC/9493-CR

Global Ischemic Stroke Surgery Market Research Report by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, Others), by Product Type (Catheters, Aspiration System, Guidewire, Microcatheter, Others), by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and by Region (North America, Europe, Asia Pacific, Rest of the World) Industry Forecast till 2035

Industry Overview

The global ischemic stroke surgery market reached USD 2,291.16 million in 2021 and is projected to achieve USD 7,266.15 million with a CAGR of 8.70% by the end of 2035. Ischemic stroke surgery is a medical procedure used to remove blood clots and restore blood flow to the brain. It helps reduce brain damage and improves recovery chances in patients suffering from acute ischemic stroke.

An increase in physical inactivity and poor lifestyle choices is pushing the demand in the global ischemic stroke surgery market. Advanced surgical methods and tools are making treatments more effective. Patients are also choosing less invasive procedures for quicker recovery.

The presence of limited medical infrastructure and a lack of experienced professionals is slowing the progress of the global ischemic stroke surgery industry. Still, with more research and investment, the ischemic stroke surgery market is finding new paths for development.

Industry Segmentations

In terms of product type, the global market is divided into catheters, aspiration systems, guidewires, microcatheters, and others.

Based on the type of surgery, the global ischemic stroke surgery market is classified into Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, and others.

The global ischemic stroke surgery market is segmented based on the end-users, including hospitals and clinics, ambulatory surgical centers, and others.

Regional Analysis

The ischemic stroke surgery market is still expanding rapidly in North America due to a large number of stroke cases and rising utilization of cutting-edge techniques like endovascular thrombectomy. An increasing senior population, more awareness, and technological advancements are all driving market expansion.

New research and successful treatments like thrombectomy are driving the growth of the ischemic stroke surgery market in Europe. The region's stroke treatment results are improving because of strong support for healthcare innovation.

The ischemic stroke surgery market is broadening quickly in the Asia-Pacific as governments increase their spending on research and healthcare. New treatments are becoming more widely available in nations like South Korea, Japan, and India, which is helping patients recover.

Latin America, the Middle East, and Africa are experiencing a rise in stroke-related illnesses, creating a higher demand for surgery. Better medical infrastructure and health programs are helping these regions grow in the global market.

Key Players

Major players in the global ischemic stroke surgery market are Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Cordis Corporation, Johnson & Johnson Services Inc., Koninklijke Philips N.V., Stryker, Imperative Care, Penumbra, Inc., and Phenox GmbH.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE
  • 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 RISE IN PHYSICAL INACTIVITY AND SEDENTARY LIFESTYLES
    • 4.2.2 ADOPTION AND LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS
    • 4.2.3 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
  • 4.3 RESTRAINTS
    • 4.3.1 LACK OF MEDICAL FACILITIES
    • 4.3.2 SHORTAGE OF SKILLED PROFESSIONALS
  • 4.4 OPPORTUNITIES
    • 4.4.1 R&D ACTIVITIES AND INVESTMENTS

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION AND SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON PRODUCTION
    • 5.3.3 IMPACT ON DEMAND
  • 5.4 EPIDEMIOLOGY ANALYSIS
    • 5.4.1 INCIDENCE & PREVALENCE
    • 5.4.2 NUMBER OF PROCEDURES FOR THROMBECTOMY
  • 5.5 REGULATORY ANALYSIS/HEALTHCARE SYSTEM

6 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY

  • 6.1 OVERVIEW
  • 6.2 THROMBECTOMY
  • 6.3 REVASCULARIZATION SURGERY
  • 6.4 CAROTID ENDARTERECTOMY
  • 6.5 ANGIOPLASTY
  • 6.6 OTHERS

7 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE

  • 7.1 OVERVIEW
  • 7.2 CATHETER
  • 7.3 ASPIRATION SYSTEM
  • 7.4 GUIDEWIRE
  • 7.5 MICROCATHETER
  • 7.6 OTHERS

8 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS AND CLINICS
  • 8.3 AMBUATORY SURGICAL CENTRES
  • 8.4 OTHERS

9 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 UK
    • 9.3.3 FRANCE
    • 9.3.4 ITALY
    • 9.3.5 SPAIN
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 JAPAN
    • 9.4.2 CHINA
    • 9.4.3 INDIA
    • 9.4.4 AUSTRALIA
    • 9.4.5 SOUTH KOREA
    • 9.4.6 REST OF ASIA PACIFIC
  • 9.5 REST OF THE WORLD
    • 9.5.1 MIDDLE EAST
    • 9.5.2 AFRICA
    • 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET SHARE ANAYISIS
  • 10.3 COMPETITIVE BENCHMARKING
  • 10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • 10.5 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • 10.6 KEY DEVELOPMENT ANALYSIS
  • 10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.7.1 MERGER & ACQUISITIONS
    • 10.7.2 AGREEMENT/MARKETING STRATEGIES
  • 10.8 FINANCIAL MATRIX
    • 10.8.1 SALES (USD MILLION), 2021
    • 10.8.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021

11 COMPANY PROFILES

  • 11.1 MEDTRONIC PLC
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS/SERVICES OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 ABBOTT LABORATORIES
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS/SERVICES OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 KEY STRATEGIES
  • 11.3 BOSTON SCIENTIFIC CORPORATION
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS/SERVICES OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 KEY STRATEGIES
  • 11.4 CORDIS CORPORATION
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS/SERVICES OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 KEY STRATEGIES
  • 11.5 KONINKLIJKE PHILIPS N.V
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS/SERVICES OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 STRYKER
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 SWOT ANALYSIS

1 1.6.6 KEY STRATEGIES

  • 11.7 IMPERATIVE CARE
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 KEY STRATEGIES
  • 11.8 JOHNSON & JOHNSON SERVICES, INC.
    • 11.8.1 COMPANY OVERVIEWS
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 PENUMBRA, INC.
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 SWOT ANALYSIS
    • 11.9.6 KEY STRATEGIES
  • 11.10 PHENOXYHENOX GMBH
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 KEY STRATEGIES

12 APPENDIX

  • 12.1 REFERENCES
  • 12.2 RELATED REPORTS